|
FAM82B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10950137965915E-11 |
| Normal-vs-Stage2 |
6.29340000113388E-08 |
| Normal-vs-Stage3 |
9.06480446261071E-11 |
| Normal-vs-Stage4 |
5.56119999999272E-05 |
| Stage1-vs-Stage2 |
7.867400E-01 |
| Stage1-vs-Stage3 |
3.874600E-01 |
| Stage1-vs-Stage4 |
6.869600E-01 |
| Stage2-vs-Stage3 |
2.977200E-01 |
| Stage2-vs-Stage4 |
8.284800E-01 |
| Stage3-vs-Stage4 |
3.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62825308791525E-12 |
| Normal-vs-AfricanAmerican |
2.24043006369357E-13 |
| Normal-vs-Asian |
7.130400E-02 |
| Caucasian-vs-AfricanAmerican |
8.637600E-01 |
| Caucasian-vs-Asian |
7.997200E-01 |
| AfricanAmerican-vs-Asian |
8.441600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
2.82929235595475E-12 |
| Male-vs-Female |
7.337600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.99906757814006E-12 |
| Normal-vs-Extreme_Weight |
1.65001345919791E-12 |
| Normal-vs-Obese |
4.11100042896351E-11 |
| Normal-vs-Extreme_Obese |
3.820900E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.046000E-01 |
| Normal_Weight-vs-Obese |
9.361600E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.141400E-01 |
| Extreme_Weight-vs-Obese |
1.090580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.637000E-01 |
| Obese-vs-Extreme_Obese |
7.290800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.237600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.22124532708767E-15 |
| Normal-vs-Age(61-80Yrs) |
5.99520433297585E-15 |
| Normal-vs-Age(81-100Yrs) |
1.75090000054112E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.633200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.860200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.095000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.001800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.958400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.980000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
5.01979569023092E-11 |
| Normal-VS-KIRP CIMP |
1.93690000005464E-06 |
| Normal-VS-Unclassified PRCC |
9.35029999982184E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.338800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.411800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.776200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.918200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.007200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.806400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74640302219586E-11 |
| Normal-vs-N1 |
5.75589997886539E-09 |
| Normal-vs-N2 |
1.942800E-03 |
| N0-vs-N1 |
6.808000E-01 |
| N0-vs-N2 |
9.082400E-01 |
| N1-vs-N2 |
9.371600E-01 |
|
|
